NASDAQ · NUTX

Nutex Health Inc.

$148.70 +$2.83 (+1.94%) 1D After hours

Key Metrics

$1.00B
Market cap
10.41×
P/E · TTM
$879.95M
Revenue · TTM
$96.38M
Net income
EPS · TTM $14.94
Dividend yield
Free cash flow $269.02M
Beta · 1Y 1.92
EBITDA · TTM $271.06M
Gross margin 47.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 21
    A material event was filed (Form 8-K).

    8-K - Nutex Health Inc. (0001479681) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 12
    From its Feb 2 high, the share price fell 46%.

    Peak close $161.25 on Feb 2; trough close $87.01 on Mar 12. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
  • Feb 5
    The stock moved -18.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5
  • Feb 4
    The stock moved -19.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.00B
Enterprise value$837.42M
Shares outstanding6.9M
52-wk range$77.21 – $204.00
Avg volume · 20D73.9K
Net cash $166.36M
Book value / share$53.68
IndustryServices-Business Services, Nec
ExchangeNASDAQ
About Nutex Health Inc.
IPO dateApr 4, 2022
Employees944

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E10.41
P/S1.14
P/FCF3.73
EV/EBITDA3.09
EV/Sales0.95
Graham №$134.32

Profitability

Gross 47.5%
Operating 28.4%
Net 11.0%
FCF 30.6%
ROE / ROIC 40.3% · 106.9%

Financial Health

Current ratio3.14
Quick ratio3.12
Debt / equity0.12
Debt / EBITDA 0.15Low leverage
Net cash $166.36M
Working capital$395.21M

Cash Flow · TTM

Operating CF $272.68M
Capex −$3.66M
Free cash flow $269.02M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

7 / 9
Strong fundamentals · 7 of 9 signals passing

Altman Z-Score

3.1
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$134.32 vs $148.70
Trades 1.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings